Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:59 AM ET 8-K
M&A Deal Cardinal Infrastructure Group Inc. CDNL

Cardinal Infrastructure Group Signs $358M M&A Deal with Hughes Brothers Construction Inc.

Cardinal Infrastructure Group entered into a definitive agreement to acquire Hughes Brothers Construction Inc., a Central Florida heavy civil and site development contractor, for an aggregate purchase price of $357.5 million. The consideration consists of $214.5 million in cash and $143.0 million in Class A common stock, with an additional earn-out potential of up to $162.5 million based on future EBITDA performance. The acquisition establishes a scaled platform for Cardinal in the fast-growing Florida market and is expected to close in the fourth quarter of 2026.

Value
$358M
Counterparty
Hughes Brothers Construction Inc.

“We are excited to welcome Hughes Brothers to Cardinal as we take another important step in our strategy to build the Southeast’s premier site development platform by moving into the fast-growing Central Florida market. Hughes Brothers is an exceptional founder-led business that culturally aligns with what we’re building. They bring an experienced team, both in terms of field personnel and corporate leadership, longstanding customer relationships, h”

Jeremy Spivey, CEO of Cardinal Infrastructure Group
8:51 AM ET Form 4
Insider Selling Buckle Inc BKE

Buckle Insider Bill L. Fairfield Sells $394K of Stock

Bill L. Fairfield sold 8,500 shares of Buckle Inc at $46.38 a share, worth $394K in total on Oct 15, 2026. Shares held after the trade: 44,408 (-16.1%).

Value
$394K
Shares
8,500
Price
$46.38
Holding change
-16.1%
Trade date
Oct 15, 2026
8:50 AM ET 8-K
Investor Presentation IRulya Therapeutics Inc. IRLA

IRulya Therapeutics Investor Presentation

IRulya Therapeutics Inc. (formerly Quince Therapeutics) has posted its updated Corporate Presentation for October 2026 to its website and filed it as an exhibit. The presentation provides a strategic overview of the company's product candidates, specifically LAM-001, and outlines planned clinical milestones and market opportunities in pulmonary hypertension and related lung diseases.

8:47 AM ET 8-K
Capital Raise OS Therapies Inc OSTX

OS Therapies Capital Raise of $7.2M

OS Therapies announced the initial closing of a warrant exercise inducement and exchange offer, raising $7.2 million in gross proceeds from seven accredited investors. Participating holders exercised warrants at a reduced price of $1.30 per share in exchange for new warrants to purchase an equal number of shares at $1.40. The proceeds will fund regulatory filings and commercial preparation for Herlystic™ in the U.S., U.K., EU, and Australia.

Value
$7.2M
8:46 AM ET 8-K
Business Update Bitmine Immersion Technologies, Inc. BMNR

Bitmine Immersion Technologies Business Update

Bitmine Immersion Technologies announced that its total crypto, cash, and marketable securities holdings have reached $15.1 billion. The company now holds 6.04 million ETH tokens, representing 4.9% of the total ETH supply, and continues to execute its strategy of weekly crypto accumulation.

8:46 AM ET 8-K
Business Update Tron Inc. TRON

Tron Business Update

Tron Inc. announced its successful election as one of the 27 Super Representative (SR) nodes on the TRON network, ranking #27 with 0.76 billion delegated TRX tokens. As an SR, the company will participate in block production and transaction validation to generate recurring on-chain revenue and expand its digital asset strategy beyond treasury accumulation.

Counterparty
TRON Network
8:45 AM ET 8-K
Capital Raise Dogwood Therapeutics, Inc. DWTX

Dogwood Therapeutics Capital Raise of $5M

Dogwood Therapeutics entered into a subscription agreement to sell 4,098,360 shares of common stock to its largest shareholder, Sealbond Limited (a subsidiary of CK Life Sciences), in a $5 million private placement. The proceeds will be used to fund Phase 3 preparatory activities for Halneuron® and extend the company's operational runway through March 2027.

Value
$5M
Counterparty
Sealbond Limited
8:37 AM ET Form 4
Insider Buying Agora, Inc. API

Agora CEO Bin Zhao Buys $76.9K of Stock

Bin Zhao, CEO, bought 17,345 shares of Agora, Inc. at $4.43 to $4.45 a share (average $4.44) in 2 transactions, worth $76.9K in total between Oct 15, 2026 and Oct 16, 2026. Shares held after the trade: 2,166,468 (+0.4%).

Value
$76.9K
Shares
17,345
Average price
$4.44
Role
CEO
Holding change
+0.4%
Trade date
Oct 15, 2026 to Oct 16, 2026
8:36 AM ET 8-K
M&A Deal Atkore Inc. ATKR

Atkore M&A Deal with Prysmian S.p.A.

Atkore Inc. completed its merger with Prysmian S.p.A., with Atkore becoming a wholly owned subsidiary of Prysmian. Shareholders of Atkore received $95.00 in cash per share. In connection with the closing, Atkore terminated its existing credit facilities and redeemed $400 million of its 4.25% Senior Notes due 2031.

Counterparty
Prysmian S.p.A.
8:33 AM ET 8-K
Business Update Eos Energy Enterprises, Inc. EOSE

Eos Energy Enterprises Business Update

Eos Energy Enterprises announced preliminary Q3 2026 results, expecting revenue of $82M-$83M and a gross margin loss of 53%-55%. The company reported a backlog of $765M and total cash of $344M, driven by production scaling at its Thorn Hill facility and a $87M advance from its DOE loan facility.

8:31 AM ET 8-K
Loan & Debt Agassi Sports Entertainment Corp. AASP

Agassi Sports Entertainment $1M Debt Financing with Investments AKA, LLC

Agassi Sports Entertainment Corp. entered into an amendment to a $1.0 million convertible promissory note held by Investments AKA, LLC, an entity controlled by Andre Agassi. The amendment triggered the immediate conversion of the note's principal into 200,000 shares of common stock and 200,000 warrants at a conversion price of $5.00 per unit. This transaction effectively settles the existing debt obligation in exchange for equity securities.

Value
$1M
Counterparty
Investments AKA, LLC
8:19 AM ET 8-K
M&A Deal Fuller H B Co FUL

Fuller H B Signs $1.4B M&A Deal with Ancora Holdings Group LLC

H.B. Fuller's Board of Directors unanimously rejected a second unsolicited, non-binding proposal from Ancora Holdings Group LLC to acquire the Company's Building Adhesive Solutions (BAS) business for $1.2 billion to $1.4 billion. The Board determined the offer undervalued the segment and lacked sufficient detail, though the Company will conduct a market check for select market segments and product lines by year-end 2026 to evaluate potential divestitures for deleveraging.

Value
$1.4B
Counterparty
Ancora Holdings Group LLC
8:17 AM ET 8-K
Divestiture Mks Inc MKSI

Mks Divestiture to TTM Technologies, Inc. for $650M

MKS Inc. has entered into a definitive agreement to sell its Ophir Optics business to TTM Technologies, Inc. for $650 million in cash. The transaction, which represents an 18x multiple of projected 2026 Adjusted EBITDA, is expected to close in the second quarter of 2027 and aims to strengthen MKS's balance sheet while focusing on its core semiconductor and electronics markets.

Value
$650M
Counterparty
TTM Technologies, Inc.
8:17 AM ET 8-K
Loan & Debt Teamshares Inc TMS

Teamshares $130M Debt Financing with Sound Point Agency LLC

Teamshares Inc. entered into a $130 million senior secured term loan facility with Sound Point Agency LLC to refinance a legacy $150 million credit facility. The new loan matures in October 2030 and carries an interest rate of one-month SOFR plus 9.50%. The refinancing is expected to reduce annual interest expense by approximately $5 million while addressing a near-term maturity.

Value
$130M
Counterparty
Sound Point Agency LLC
Term
4 years
8:16 AM ET 8-K
M&A Deal Ttm Technologies Inc TTMI

Ttm Technologies Signs $650M M&A Deal with MKS Inc.

TTM Technologies has entered into a definitive agreement to acquire the Ophir Optics business from MKS Inc. for approximately $650 million in an all-cash transaction. The acquisition adds high-precision infrared thermal imaging and laser optics capabilities to TTM's defense and industrial portfolio and is expected to close in the second quarter of 2027.

Value
$650M
Counterparty
MKS Inc.

“We are excited to announce our planned acquisition of the Ophir Optics business as another important step toward enhancing our long-term growth strategy by expanding our portfolio with mission-critical optical solutions for land, air, maritime, and unmanned platforms and our industrial portfolio.”

Edwin Roks, President and Chief Executive Officer
8:11 AM ET 8-K
Business Update DeFi Development Corp. DFDV

DeFi Development Business Update

DeFi Development Corp. reported its weekly treasury update, increasing its SOL holdings by 3,983 to a total of 2,590,266 SOL and SOL equivalents. The company also announced an increase in the annual dividend rate for its Series C Perpetual Preferred Stock (CHAD) from 13% to 14%, effective November 2, 2026.

8:10 AM ET 8-K
Deal Termination Callan Jmb Inc. CJMB

Callan Jmb Deal Termination with The Pfanenstiel Company, LLC

Callan JMB Inc., through its subsidiary Callan Power LLC, has terminated its previously announced Asset Purchase and Sale Agreement with The Pfanenstiel Company, LLC. The company cited insufficient due diligence results as the reason for exercising its right to terminate the deal, which involved acquiring a 50% interest in oil and gas leases in North Dakota and Montana. As a result of the termination, the company no longer intends to raise the additional capital that would have been required to fund the acquisition.

Counterparty
The Pfanenstiel Company, LLC
8:10 AM ET 8-K
Executive Compensation Expand Energy Corp EXE

Expand Energy Executive Compensation

Expand Energy Corporation appointed Daniel E. Brown as President and Chief Executive Officer, effective October 26, 2026. Mr. Brown's compensation package includes a $1,000,000 base salary, a 125% target bonus, and a make-whole equity award valued at approximately $15.65 million to compensate for forfeited compensation from his previous role at Chord Energy.

Counterparty
Daniel E. Brown
8:08 AM ET 8-K
Clinical Trial Data ArriVent BioPharma, Inc. AVBP

ArriVent BioPharma Clinical Trial Data

ArriVent BioPharma announced the publication of Phase 1b results for firmonertinib in the journal Cancer Cell, focusing on patients with advanced EGFR PACC-mutant non-small cell lung cancer (NSCLC). The data showed a confirmed overall response rate (ORR) of 68% at the 240 mg dose and a median progression-free survival of 16.0 months, supporting the ongoing global Phase 3 ALPACCA trial.

8:08 AM ET 8-K
Executive Compensation Mattel Inc MAT

Mattel Executive Compensation

Mattel, Inc. has appointed Peter Griffith as Chief Financial Officer and a member of the Board of Directors, effective October 20, 2026, succeeding Paul Ruh. Mr. Griffith's compensation package includes an annual base salary of $1,300,000, a 100% target bonus opportunity, and an inducement performance-based RSU award valued at $3,300,000. He also receives prorated 2026 and 2027 RSU grants totaling $3,500,000 as part of his new-hire agreement.

Counterparty
Peter Griffith
8:06 AM ET 8-K
M&A Deal Silence Therapeutics plc SLN

Silence Therapeutics Signs $1.3B M&A Deal with Merck KGaA, Darmstadt, Germany

Silence Therapeutics has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany for approximately $1.3 billion in cash. Under the terms of the deal, Silence shareholders will receive $20.00 per ADS, representing a 130% premium to the company's recent closing price. The acquisition aims to strengthen Merck KGaA's specialty and rare disease pipeline, specifically incorporating Silence's Phase 2 siRNA candidate, Divesiran.

Value
$1.3B
Counterparty
Merck KGaA, Darmstadt, Germany

“We are pleased to have reached this agreement with Merck KGaA, Darmstadt, Germany, which is the result of a competitive sale process and delivers significant, immediate and certain value to our shareholders.”

Iain Ross, Interim Principal Executive Officer and Chairman of the Silence Board

“The planned acquisition of Silence Therapeutics will strengthen our capabilities to serve patients with targeted specialty and rare diseases.”

Kai Beckmann, Chairman of the Executive Board and Group CEO of Merck KGaA, Darmstadt, Germany
8:05 AM ET 8-K
Business Update Clene Inc. CLNN

Clene Business Update

Clene Inc. has submitted a New Drug Application (NDA) to the FDA seeking accelerated approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis (ALS). The submission is based on neurofilament light chain biomarker data and clinical outcomes, with the company also preparing for a confirmatory Phase 3 RESTORE-ALS study.

Counterparty
FDA
8:02 AM ET 8-K
Financial Results Dynex Capital Inc DX

Dynex Capital Financial Results

Dynex Capital reported a third quarter net loss of $1.34 per share and a total economic return of (11.5)%, driven primarily by wider Agency MBS spreads that reduced book value to $10.91. Despite the book value decline, the company maintained strong liquidity of $1.3 billion and raised $384 million in capital during the quarter through its ATM program and a preferred stock issuance.

Term
Q3 2026

“We believe today’s Agency mortgage market presents a compelling forward investment opportunity. Late-quarter volatility and wider mortgage spreads reduced our reported book value, and that repricing has created an attractive forward return opportunity. Importantly, the mortgage market remains fundamentally solid, technical conditions are strong, and financing remains stable. We are managing for the long term, prepared for a range of market scenarios, and positioned to capitalize on opportunities as they develop.”

Smriti Laxman Popenoe, Co-Chief Executive Officer and President
8:00 AM ET 8-K
Business Update CorMedix Inc. CRMD

CorMedix Business Update

CorMedix announced that the FDA has accepted for filing a supplemental New Drug Application (sNDA) for REZZAYO (rezafungin for injection) for the prophylaxis of invasive fungal disease. The FDA granted Priority Review for the application, which is supported by positive Phase III ReSPECT study data, and set a PDUFA target action date in Q1 2027.

Counterparty
FDA
8:00 AM ET 8-K
Stock Buyback Strategy Inc MSTR

Strategy Announces $1B Stock Buyback

Strategy Inc announced that its board of directors approved a $1.0 billion increase to its digital credit securities repurchase program, raising the total authorization from $2.0 billion to $3.0 billion. During the week of October 12, 2026, the company also repurchased approximately 1.94 million shares of its STRC preferred stock for $193.1 million and sold $22.0 million of Class A common stock to fund bitcoin purchases.

Value
$1B
8:00 AM ET 8-K
Capital Raise Super League Enterprise, Inc. SLE

Super League Enterprise Capital Raise of $135M

Super League stockholders approved a strategic investment from Metaplanet, Inc. involving the contribution of 2,100 Bitcoin and $2.5 million in cash. Upon closing, the company will be renamed Superplanet, Inc. and issue 44,859,400 shares of common stock at $3.00 per share, establishing a Bitcoin-based treasury platform.

Value
$135M
Counterparty
Metaplanet Holdings, Inc.

“I’m deeply grateful to our stockholders for their support. Their approval brings us one step closer to redefining what this company can become. If the transaction closes, we would no longer be defined solely by our current scale. Alongside an operating business that continues to serve many of the world’s most recognizable brands, we would have a treasury seeded with 2,100 Bitcoin and the potential to build a significant position over time.”

Matt Edelman, Chairman, Chief Executive Officer and President of Super League
7:59 AM ET 8-K
Business Update Strive, Inc. ASST

Strive Business Update

Strive, Inc. provided an operational update disclosing the purchase of 4,045 bitcoin between October 12 and October 16, 2026, bringing its total holdings to 36,818 bitcoin. The company also reported updates to its cash position, share count, and the full exercise or expiration of its outstanding traditional warrants.

7:42 AM ET 8-K
M&A Deal Centrus Energy Corp LEU

Centrus Energy Signs $116M M&A Deal with Westerman Holdings, LLC

Centrus Energy Corp. acquired 100% of Westerman Holdings, LLC, a U.S. equipment manufacturing and engineering firm, for approximately $116 million in a mix of cash and stock. The acquisition brings a key supplier of centrifuge components in-house to secure Centrus' supply chain and diversify its revenue base into non-nuclear industrial sectors. Westerman will operate as a wholly owned subsidiary, and its CEO Jacob Garrett will transition to President of the unit and Vice President of Centrus.

Value
$116M
Counterparty
Westerman Holdings, LLC
7:35 AM ET 8-K
M&A Deal Silgan Holdings Inc SLGN

Silgan Holdings Signs $3.4B M&A Deal with Trivium Packaging B.V.

Silgan Holdings announced a transformational deal to combine its Metal Containers and flat cap closures businesses with Trivium Packaging B.V. to create a new $7.3 billion partnership called Silgan Metal Containers and Closures (Silgan MCC). Silgan will retain a 60% controlling interest in the partnership while receiving $2.3 billion in cash proceeds, with the acquisition of Trivium valued at an enterprise value of approximately $3.4 billion.

Value
$3.4B
Counterparty
Trivium Packaging B.V.

“This strategic portfolio acceleration reflects our commitment to value creation through deliberate portfolio construction and strategic capital deployment, enabled by the strength of our businesses and our exceptional teams.”

Adam Greenlee, President and Chief Executive Officer
7:24 AM ET 8-K
Stock Buyback News Corp NWSA

News Stock Buyback Update

News Corp provided a daily update on its existing $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The filing includes specific transaction notifications for the repurchase of Class A and Class B common stock in the open market.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.